Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
JZL184: A Practical MAGL Research Workflow
2026-10-02
JZL184 provides a controllable way to increase 2-arachidonoylglycerol signaling and test how MAGL activity shapes CB1-dependent synaptic, astrocytic, and behavioral phenotypes. This workflow connects formulation, TBI-related GLT-1 assays, neuronal physiology, and troubleshooting while separating established findings from pilot recommendations.
-
Neurotensin: GPCR Trafficking Workflow Guide
2026-10-01
Neurotensin provides a controllable ligand-based way to interrogate NTR1 signaling, receptor recycling, and miR-133α responses in gastrointestinal models. This workflow combines time-resolved cell assays with practical handling controls and a cautious, data-informed approach to fluorescence interference.
-
Fiber Density Rebuilds AF Collagen Heterogeneity
2026-10-01
The reference study identifies electrospun fiber density as a controllable mechanical cue that directs annulus fibrosus cell phenotypes toward collagen type I- or collagen type II-enriched matrix programs. Its results connect scaffold microarchitecture with RhoA–ROCK, ERK/AKT, and Piezo1-associated mechanotransduction, providing a design rationale for spatially organized annulus fibrosus repair.
-
Podophyllotoxin: An Assay-First Research Framework
2026-09-30
Podophyllotoxin is a powerful microtubule-disrupting tool for studying mitotic arrest, apoptosis, autophagy, and drug resistance. This assay-first guide distinguishes parent-compound evidence from derivative data and shows how to build more defensible cancer-biology workflows.
-
MitMAB for Mechanistic Organoid Uptake Studies
2026-09-30
MitMAB provides a pharmacological way to test dynamin-dependent uptake in polarized intestinal organoids. This article connects milk-derived extracellular vesicle biology with assay design, interpretation, controls, and membrane-trafficking limitations.
-
2X Taq PCR Master Mix in Neuroblastoma Research
2026-09-29
Discover how 2X Taq PCR Master Mix can support DNA validation workflows inspired by new neuroblastoma glycosylation research. This article connects spatial glycomics, GMDS biology, endpoint PCR, cloning, and assay-quality decisions without confusing DNA amplification with direct glycan measurement.
-
Cdc42-Targeted Signaling in Kidney Fibrosis
2026-09-29
Hu et al. identified the natural daphne diterpenoid daphnepedunin A as an anti-fibrotic lead that directly targets Cdc42 and disrupts a Cdc42–PKCζ–GSK-3β–β-catenin signaling axis. The study combines chemical investigation, thermal proteome profiling, renal fibroblast assays, and unilateral ureteral obstruction models to connect target engagement with reduced kidney fibrosis.
-
Coumestrol: From ER Antagonism to RA Ferroptosis
2026-09-28
Coumestrol links estrogen receptor pharmacology with PMAIP1-dependent ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes. This thought-leadership analysis examines the mechanistic rationale, experimental controls, translational value, and strategic use of Coumestrol as a phytoestrogen estrogen receptor antagonist and selective estrogen receptor modulator research compound.
-
MitMAB for Organoid Endocytosis Research
2026-09-28
Use MitMAB as a timed perturbation to test whether dynamin-dependent uptake contributes to extracellular-vesicle internalization in intestinal models. Pair it with polarity-aware organoids, vehicle and viability controls, and orthogonal uptake measurements to distinguish reduced entry from nonspecific membrane or cell effects.
-
Mdivi-1 Workflows for DRP1 and Vascular Crosstalk
2026-09-27
Use Mdivi-1 to test how DRP1-linked mitochondrial fission contributes to endothelial–smooth muscle signaling, apoptosis, and cell behavior—not simply to label a pathway. This workflow pairs conditioned-medium experiments with practical dosing, controls, and troubleshooting while distinguishing the hypoxic pulmonary hypertension findings from separate retinal neuroprotection evidence.
-
Podophyllotoxin Workflows for Cancer Biology
2026-09-26
Use Podophyllotoxin as a microtubule-targeting perturbation to investigate mitotic arrest, cell viability, and downstream cell-death responses—with controls that distinguish assay effects from mechanism. A 2024 hepatocellular carcinoma study offers a useful comparison for autophagy experiments, but its findings concern the separate diterpene JXE-23, not Podophyllotoxin.
-
Luminescent ATP Detection Assay Kit in ICD Research
2026-09-25
Measure ATP as a functional readout when investigating foretinib-induced immunogenic cell death—not as a stand-alone marker of it. This guide shows how to distinguish extracellular ATP release from cellular ATP content, build a practical luminescence workflow, and interpret the result alongside other evidence of immune activation.
-
Podophyllotoxin in Drug-Resistance Assay Design
2026-09-25
Podophyllotoxin is a microtubule-targeting tool for studying mitotic disruption, cell fate, and cancer drug resistance. This guide separates evidence for the parent compound from findings on a dual-action derivative and shows how that distinction can sharpen assay design.
-
Fus3–RNS1 Links Fungal Metabolism to Infection
2026-09-24
Meng and colleagues identify a Fus3-MAPK–RNS1 cascade that connects nutrient-responsive gene regulation with cuticle degradation and insect infection by Metarhizium robertsii. The findings suggest that this pathway supports both entomopathogenic growth and use of complex, less-preferred nutrients, while leaving open how broadly the mechanism operates across fungi.
-
Fucoidan in MCF-7 Breast Cancer Assays
2026-09-24
A practical guide to using Fucoidan to probe breast cancer cell growth, migration, colony formation, and caveolin-1 expression. It translates a recent MCF-7 study into an assay workflow while flagging the solubility and vehicle controls that can make or break interpretation.